Publications by authors named "Ferdinand Luger"

Claim this Profile
E
Enfortumab vedotin plus pembrolizumab in treatment-naïve metastatic urothelial carcinoma patients: An Austrian real-world analysis.
Dora Niedersuess-Beke, Karl Mayrhofer, Johanna Krauter, Johannes Franke, Dominic Vais, Ferdinand Luger

Int J Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microultrasonography-Guided vs MRI-Guided Biopsy for Prostate Cancer Diagnosis: The OPTIMUM Randomized Clinical Trial.
Adam Kinnaird, Ferdinand Luger, Hannes Cash, Sangeet Ghai, L Felipe Urdaneta-Salegui

JAMA· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world Evidence for Enfortumab Vedotin in Patients with Metastatic Urothelial Cancer: An Austrian Multicentre Study.
Dora Niedersuess-Beke, Karl Mayrhofer, Johanna Krauter, Susanne Schnabel, Simon Peter Gampenrieder, Ferdinand Luger

Clin Genitourin Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Evidence of Triplet Therapy in Metastatic Hormone-Sensitive Prostate Cancer: An Austrian Multicenter Study.
Mona Kafka, Giulia Giannini, Nastasiia Artamonova, Hannes Neuwirt, Heidemarie Ofner, Ferdinand Luger

Clin Genitourin Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Importance of genetic testing in prostate cancer].
Lukas Steinkellner, Ferdinand Luger, Wolfgang Loidl

Urologie· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A non-inferiority comparative analysis of micro-ultrasonography and MRI-targeted biopsy in men at risk of prostate cancer.
Sebastian L Hofbauer, Ferdinand Luger, Niklas Harland, Henning Plage, Maximillian Reimann

BJU Int· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of micro-ultrasound and multiparametric magnetic resonance imaging for prostate cancer: A multicenter, prospective analysis.
Laurence Klotz, Giovanni Lughezzani, Davide Maffei, Andrea Sánchez, José Gregorio Pereira, Ferdinand Luger

Can Urol Assoc J· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Critical assessment of preoperative urinary prostate cancer antigen 3 on the accuracy of prostate cancer staging.
Marco Auprich, Felix K-H Chun, John F Ward, Karl Pummer, Richard Babaian, Ferdinand Luger

Eur Urol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis